<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_systemic" title="The Systemic Immune Response to Collagen-Induced Arthritis and the Impact of Bone Injury in Inflammatory Conditions" shortTitle="systemic" author="José  H. Teixeira, Andreia  M. Silva, Maria  Inês Almeida, Mafalda Bessa-Gonçalves, Carla Cunha, Mário  A. Barbosa, Susana  G. Santos" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1422-0067/20/21/5436/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
</s>
<s type="frag">
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Rheumatoid	NNP	Rheumatoid
arthritis	NN	arthritis
(	-LRB-	(
RA	NNP	RA
)	-RRB-	)
is	VBZ	be
an	DT	a
autoimmune	JJ	autoimmune
condition	NN	condition
,	,	,
characterized	VBN	characterize
by	IN	by
symmetrical	JJ	symmetrical
joint	NN	joint
inflammation	NN	inflammation
,	,	,
that	WDT	that
affects	VBZ	affect
approximately	RB	approximately
1	CD	1
%	NN	%
of	IN	of
the	DT	the
world	NN	world
’s	POS	's
population	NN	population
.	.	.
</s>
<s type="decl">
RA	NNP	RA
is	VBZ	be
characterized	VBN	characterize
mainly	RB	mainly
by	IN	by
synovium	NN	synovium
hyperplasia	NN	hyperplasia
and	CC	and
a	DT	a
joint	JJ	joint
destruction	NN	destruction
process	NN	process
.	.	.
</s>
<s type="decl">
In	IN	in
this	DT	this
scenario	NN	scenario
,	,	,
immune	JJ	immune
cells	NNS	cell
and	CC	and
the	DT	the
inflammatory	JJ	inflammatory
microenvironment	NN	microenvironment
that	WDT	that
they	PRP	they
create	VBP	create
in	IN	in
affected	VBN	affect
joints	NNS	joint
are	VBP	be
key	JJ	key
components	NNS	component
in	IN	in
the	DT	the
pathophysiology	NN	pathophysiology
of	IN	of
RA	NNP	RA
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
it	PRP	it
is	VBZ	be
well-described	JJ	well-described
that	IN	that
during	IN	during
the	DT	the
inflammatory	JJ	inflammatory
stages	NNS	stage
of	IN	of
the	DT	the
disease	NN	disease
,	,	,
extra-articular	JJ	extra-articular
manifestations	NNS	manifestation
are	VBP	be
common	JJ	common
,	,	,
which	WDT	which
involve	VBP	involve
other	JJ	other
tissues	NNS	tissue
or	CC	or
organs	NNS	organ
.	.	.
</s>
</p>
<p>
<s type="decl">
RA	NN	RA
patients	NNS	patient
are	VBP	be
at	IN	at
risk	NN	risk
of	IN	of
systemic	JJ	systemic
complications	NNS	complication
and	CC	and
several	JJ	several
co-morbidities	NNS	co-morbidity
,	,	,
including	VBG	include
osteoporosis	NN	osteoporosis
and	CC	and
frequent	JJ	frequent
vertebral	JJ	vertebral
and	CC	and
hip	NN	hip
fragility	NN	fragility
fractures	NNS	fracture
.	.	.
</s>
<s type="decl">
The	DT	the
incidence	NN	incidence
rate	NN	rate
of	IN	of
overall	JJ	overall
fractures	NNS	fracture
in	IN	in
RA	NN	RA
patients	NNS	patient
is	VBZ	be
33	CD	33
per	IN	per
1000	CD	1000
person-years	NNS	person-year
,	,	,
and	CC	and
the	DT	the
risk	NN	risk
is	VBZ	be
increased	VBN	increase
with	IN	with
disease	NN	disease
activity	NN	activity
and	CC	and
associated	VBN	associate
with	IN	with
overexpression	NN	overexpression
of	IN	of
pro-inflammatory	JJ	pro-inflammatory
cytokines	NNS	cytokine
that	WDT	that
can	MD	can
disturb	VB	disturb
the	DT	the
bone	NN	bone
remodeling	NN	remodeling
process	NN	process
.	.	.
</s>
</p>
<p>
<s type="decl">
Over	IN	over
the	DT	the
last	JJ	last
decades	NNS	decade
,	,	,
animal	NN	animal
models	NNS	model
—	:	—
especially	RB	especially
the	DT	the
rodent	NN	rodent
models	NNS	model
—	:	—
have	VBP	have
been	VBN	be
crucial	JJ	crucial
tools	NNS	tool
for	IN	for
understanding	VBG	understand
the	DT	the
biologic	JJ	biologic
process	NN	process
of	IN	of
RA	NN	RA
,	,	,
and	CC	and
their	PRP$	their
use	NN	use
can	MD	can
aid	VB	aid
in	IN	in
developing	VBG	develop
new	JJ	new
therapeutic	JJ	therapeutic
strategies	NNS	strategy
for	IN	for
fracture	NN	fracture
healing	NN	healing
in	IN	in
RA	NN	RA
inflammatory	JJ	inflammatory
conditions	NNS	condition
.	.	.
</s>
<s type="decl">
Collagen	NN	collagen
induced-arthritis	NN	induced-aritis
(	-LRB-	(
CIA	NNP	CIA
)	-RRB-	)
animal	NN	animal
models	NNS	model
have	VBP	have
been	VBN	be
one	CD	one
of	IN	of
the	DT	the
most	RBS	most
widely	RB	widely
used	VBN	use
models	NNS	model
in	IN	in
RA	NNP	RA
research	NN	research
.	.	.
</s>
<s type="decl">
Originally	RB	originally
described	VBN	describe
by	IN	by
Trentham	NNP	Trentham
,	,	,
CIA	NNP	CIA
is	VBZ	be
a	DT	a
reproducible	JJ	reproducible
animal	NN	animal
experimental	JJ	experimental
model	NN	model
of	IN	of
RA	NNP	RA
.	.	.
</s>
<s type="decl">
In	IN	in
fact	NN	fact
,	,	,
the	DT	the
similarity	NN	similarity
to	IN	to
human	JJ	human
RA	NN	RA
regarding	VBG	regard
the	DT	the
disease	NN	disease
clinical	JJ	clinical
,	,	,
histological	JJ	histological
,	,	,
and	CC	and
immunological	JJ	immunological
signals	NNS	signal
—	:	—
including	VBG	include
high	JJ	high
articular	JJ	articular
levels	NNS	level
of	IN	of
inflammatory	JJ	inflammatory
cytokines	NNS	cytokine
—	:	—
like	IN	like
tumor	NN	tumor
necrosis	NN	necrosis
factor-α	NN	factor-α
(	-LRB-	(
TNF-α	NNP	TNF-α
)	-RRB-	)
,	,	,
make	VBP	make
it	PRP	it
an	DT	a
invaluable	JJ	invaluable
model	NN	model
to	TO	to
study	VB	study
the	DT	the
pathologic	JJ	pathologic
process	NN	process
and	CC	and
to	TO	to
search	VB	search
new	JJ	new
therapeutic	JJ	therapeutic
strategies	NNS	strategy
.	.	.
</s>
<s type="decl">
The	DT	the
response	NN	response
to	IN	to
rat	NN	rat
CIA	NNP	CIA
has	VBZ	have
been	VBN	be
reported	VBN	report
to	TO	to
involve	VB	involve
macrophages	NNS	macrophage
,	,	,
T	NN	T
and	CC	and
B	NN	B
lymphocytes	NNS	lymphocyte
,	,	,
and	CC	and
mediators	NNS	mediator
such	JJ	such
as	IN	as
TNF-α	NNP	TNF-α
,	,	,
Interleukin	NNP	Interleukin
(	-LRB-	(
IL)-1β	NNP	IL)-1β
,	,	,
IL-6	NNP	IL-6
,	,	,
and	CC	and
IL-17	NNP	IL-17
.	.	.
</s>
<s type="decl">
Nonetheless	RB	nonetheless
,	,	,
the	DT	the
systemic	JJ	systemic
response	NN	response
in	IN	in
this	DT	this
model	NN	model
has	VBZ	have
not	RB	not
been	VBN	be
well	RB	well
characterized	VBN	characterize
so	RB	so
far	RB	far
.	.	.
</s>
</p>
<p>
<s type="decl">
Importantly	RB	importantly
,	,	,
current	JJ	current
RA	NN	RA
treatments	NNS	treatment
do	VBP	do
not	RB	not
promote	VB	promote
joint	JJ	joint
repair	NN	repair
,	,	,
and	CC	and
several	JJ	several
efforts	NNS	effort
are	VBP	be
being	VBG	be
made	VBN	make
to	TO	to
develop	VB	develop
new	JJ	new
therapies	NNS	therapy
,	,	,
especially	RB	especially
based	VBN	base
in	IN	in
cell	NN	cell
approaches	NNS	approach
using	VBG	use
mesenchymal	JJ	mesenchymal
stem/stromal	NN	stem/stromal
cells	NNS	cell
(	-LRB-	(
MSC	NNP	MSC
)	-RRB-	)
.	.	.
</s>
<s type="decl">
MSC	NNP	MSC
are	VBP	be
multipotent	JJ	multipotent
progenitor	NN	progenitor
cells	NNS	cell
with	IN	with
the	DT	the
potential	NN	potential
to	TO	to
differentiate	VB	differentiate
into	IN	into
mesenchymal	JJ	mesenchymal
lineage	NN	lineage
tissues	NNS	tissue
(	-LRB-	(
e.g.	FW	e.g.
,	,	,
bone	NN	bone
,	,	,
cartilage	NN	cartilage
,	,	,
and	CC	and
adipose	NN	adipose
tissue	NN	tissue
)	-RRB-	)
,	,	,
described	VBN	describe
to	TO	to
have	VB	have
immunomodulatory	JJ	immunomodulatory
roles	NNS	role
,	,	,
being	VBG	be
capable	JJ	capable
of	IN	of
recruiting	VBG	recruit
different	JJ	different
cell	NN	cell
types	NNS	type
and	CC	and
promoting	VBG	promote
tissue	NN	tissue
repair	NN	repair
.	.	.
</s>
<s type="decl">
The	DT	the
transplantation	NN	transplantation
of	IN	of
MSC	NNP	MSC
has	VBZ	have
been	VBN	be
reported	VBN	report
to	TO	to
ameliorate	VB	ameliorate
or	CC	or
delay	VB	delay
RA	NNP	RA
onset	NN	onset
in	IN	in
CIA	NNP	CIA
animals	NNS	animal
,	,	,
partially	RB	partially
mediated	VBN	mediate
by	IN	by
inflammatory	JJ	inflammatory
signaling	NN	signaling
suppression	NN	suppression
,	,	,
and	CC	and
thereby	RB	thereby
reducing	VBG	reduce
joint	JJ	joint
swelling	NN	swelling
and	CC	and
destruction	NN	destruction
.	.	.
</s>
<s type="decl">
Although	IN	although
the	DT	the
available	JJ	available
evidence	NN	evidence
supports	VBZ	support
the	DT	the
use	NN	use
of	IN	of
MSC	NNP	MSC
transplantation	NN	transplantation
as	IN	as
a	DT	a
cell-based	JJ	cell-based
strategy	NN	strategy
in	IN	in
CIA	NNP	CIA
animals	NNS	animal
,	,	,
data	NNS	datum
on	IN	on
the	DT	the
biology	NN	biology
of	IN	of
endogenous	JJ	endogenous
CIA	NNP	CIA
animals-derived	JJ	animals-derived
MSC	NN	MSC
in	IN	in
basal	JJ	basal
conditions	NNS	condition
is	VBZ	be
scarce	JJ	scarce
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
the	DT	the
impact	NN	impact
of	IN	of
the	DT	the
systemic	JJ	systemic
inflammatory	JJ	inflammatory
condition	NN	condition
on	IN	on
biological	JJ	biological
properties	NNS	property
of	IN	of
endogenous	JJ	endogenous
MSC	NNP	MSC
has	VBZ	have
not	RB	not
been	VBN	be
explored	VBN	explore
yet	RB	yet
.	.	.
</s>
</p>
<p>
<s type="decl">
Herein	RB	herein
,	,	,
we	PRP	we
propose	VBP	propose
CIA	NNP	CIA
as	IN	as
a	DT	a
reliable	JJ	reliable
model	NN	model
to	TO	to
study	VB	study
bone	NN	bone
regeneration	NN	regeneration
in	IN	in
inflammatory	JJ	inflammatory
conditions	NNS	condition
,	,	,
and	CC	and
additionally	RB	additionally
we	PRP	we
investigate	VBP	investigate
the	DT	the
effect	NN	effect
of	IN	of
RA	NN	RA
induction	NN	induction
on	IN	on
the	DT	the
biological	JJ	biological
behavior	NN	behavior
of	IN	of
endogenous	JJ	endogenous
MSC	NNP	MSC
as	IN	as
crucial	JJ	crucial
cells	NNS	cell
involved	VBN	involve
in	IN	in
repair/regeneration	NN	repair/regeneration
.	.	.
</s>
</p>
<p>
<s type="decl">
Our	PRP$	our
results	NNS	result
have	VBP	have
shown	VBN	show
that	IN	that
the	DT	the
combination	NN	combination
of	IN	of
the	DT	the
two	CD	2
models	NNS	model
is	VBZ	be
feasible	JJ	feasible
and	CC	and
that	IN	that
CIA	NNP	CIA
animals	NNS	animal
respond	VBP	respond
to	IN	to
the	DT	the
bone	NN	bone
injury	NN	injury
with	IN	with
a	DT	a
significant	JJ	significant
increase	NN	increase
of	IN	of
systemic	JJ	systemic
myeloid	NN	myeloid
cells	NNS	cell
number	NN	number
and	CC	and
their	PRP$	their
co-stimulatory	JJ	co-stimulatory
molecules	NNS	molecule
(	-LRB-	(
CD40	NNP	CD40
and	CC	and
CD86	NN	CD86
)	-RRB-	)
expression	NN	expression
,	,	,
accompanied	VBN	accompany
by	IN	by
increased	VBN	increase
levels	NNS	level
of	IN	of
IL-13	NNP	IL-13
,	,	,
IL-2	NNP	IL-2
,	,	,
and	CC	and
IL-6	NNP	IL-6
in	IN	in
plasma	NN	plasma
.	.	.
</s>
<s type="decl">
The	DT	the
systemic	JJ	systemic
inflammatory	JJ	inflammatory
environment	NN	environment
created	VBN	create
by	IN	by
the	DT	the
arthritis	NN	arthritis
induction	NN	induction
leads	VBZ	lead
to	IN	to
decreased	VBN	decrease
metabolic	JJ	metabolic
activity	NN	activity
and	CC	and
proliferation	NN	proliferation
of	IN	of
CIA-derived	NNP	CIA-derived
MSC	NN	MSC
,	,	,
and	CC	and
increased	VBN	increase
differentiation	NN	differentiation
capacity	NN	capacity
determined	VBN	determine
by	IN	by
the	DT	the
expression	NN	expression
of	IN	of
osteogenic	JJ	osteogenic
(	-LRB-	(
runt-related	JJ	runt-related
transcription	NN	transcription
factor	NN	factor
2	CD	2
(	-LRB-	(
RUNX2	NNP	RUNX2
)	-RRB-	)
and	CC	and
alkaline	NN	alkaline
phosphatase	NN	phosphatase
(	-LRB-	(
ALP	NNP	ALP
)	-RRB-	)
)	-RRB-	)
,	,	,
and	CC	and
chondrogenic	NN	chondrogenic
(	-LRB-	(
aggrecan	NN	aggrecan
(	-LRB-	(
ACAN	NNP	ACAN
)	-RRB-	)
)	-RRB-	)
markers	NNS	marker
in	IN	in
basal	JJ	basal
conditions	NNS	condition
.	.	.
</s>
</p>
</text>